XAU/USD4,699.34+0.28% BTC/USD77,811-0.76% ETH/USD2,321-0.29% SOL/USD186.34+0.43% EUR/USD1.0934+0.12% GBP/USD1.2641-0.08% USD/JPY153.42+0.22% AVAX/USD9.44+0.35% WTI78.21+1.04% DXY104.18-0.14% SPX5,812+0.31% NDX20,341+0.48% XAU/USD4,699.34+0.28% BTC/USD77,811-0.76% ETH/USD2,321-0.29% SOL/USD186.34+0.43% EUR/USD1.0934+0.12% GBP/USD1.2641-0.08% USD/JPY153.42+0.22% AVAX/USD9.44+0.35% WTI78.21+1.04% DXY104.18-0.14% SPX5,812+0.31% NDX20,341+0.48%
ZEROWFX
EN تسجيل الدخول
الخليج 13س مضت المصدر: Menafn

U.S. Supreme Court Backs Hikma In Vascepa Patent Dispute

(MENAFN - Jordan News Agency) Amman, June 5 (Petra)-- The U.S. Supreme Court has ruled that Hikma Pharmaceuticals' generic version of the cardiovascular drug Vascepa does not infringe patents held ...

U.S. Supreme Court Backs Hikma In Vascepa Patent Dispute
(MENAFN - Jordan News Agency) Amman, June 5 (Petra)-- The U.S. Supreme Court has ruled that Hikma Pharmaceuticals' generic version of the cardiovascular drug Vascepa does not infringe patents held ...
كل الأخبار → أخبار الفوركس أخبار الكريبتو التقويم الاقتصادي
خطط لصفقتك القادمة
حاسبة حجم اللوت حاسبة المخاطرة دليل تداول الذهب XAUUSD إدارة المخاطر